Finnrick - Ensuring a Safer and More Transparent Supply Chain
Qianmiao Peptide

Qianmiao Peptide

Retatrutide

Finnrick tested 6 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Qianmiao Peptide between 15 Jan 2026 and 18 Feb 2026. Test scores average over 5, no score below 4, and at least 6 tests warrant a confident Finnrick Rating of C (Okay).

Finnrick Rating™
Qianmiao Peptide
Retatrutide
Tested 6 Samples
Last test 18 Feb 2026

Take Action

Researcher

Request Full Data Access to the Finnrick database of peptide tests.

Free peptide testing

Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.

Other Retatrutide tests from top-rated vendors:

All Retatrutide tests from Qianmiao Peptide

Samples are tested in commercial labs

Tests Count

6

Scores

AVG7.0MIN4.2MAX9.5

Last

18 Feb 2026

First

15 Jan 2026
Quantity
Test DateCertificate
Test Score
LabelTestedDifferencePurityBatch IDContainerTested AtSent By
18 Feb 2026View7.115mg16.8mg+12.0%99.53%Nov, 2025No Label / Silver Crimp / Orange CapLab EPublic
10 Feb 2026View9.520mg20.3mg+1.5%99.70%12/02/25No Label / Gold Crimp / Clear CapLab GPublic
4 Feb 2026View8.310mg10.7mg+7.0%99.50%FE RT10 DECEMBER 2 2025White Label / Silver Crimp / Yellow CapLab GPublic
4 Feb 2026View6.720mg25mg+25.0%99.80%FE RT20 JANUARY 2 2026White Label / Gold Crimp / Clear CapLab GPublic
22 Jan 2026View4.210mg16.3mg+63.0%99.80%(no batch ID)No Label / Silver Crimp / Yellow CapLab GPublic
15 Jan 2026View6.215mg13.6mg-9.3%99.70%(no batch ID)No Label / Silver Crimp / Orange CapLab GPublic